Seres Therapeutics, Inc. - 8-K Filing
Marella Thorell resigns as Executive Vice President and Chief Financial Officer of Seres Therapeutics, Inc. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $MCRB